ArticleAsian bioethics review2026
The Harms of Family-Oriented Informed Consent in Clinical Practice in Two Megacities in Northern China: a Sociological and Ethical Study.
Article in Asian bioethics review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In clinical practice in China, a family-oriented approach to informed consent is widely used. Under this approach, families may control whether patients are provided with information and make medical decisions for the patient without asking what they would want. One of the main justifications is its purported benefits for patients. Recent studies have begun to expose ways in which this approach may be more harmful than beneficial to patients. Integrating empirical investigation with normative analysis, this study examines the experienced and perceived benefits and harms of family-oriented informed consent by Chinese patients, family caregivers, and healthcare professionals from two megacities. Semi-structured and in-depth interviews were undertaken with 13 patients, 14 family caregivers, and 9 medical professionals in Tianjin and Beijing, two megacities in northern China. The findings of these interviews were thematically analysed. When taking the perspective of a caregiver, most of the participants across the three groups described the family-oriented approach as more beneficial to patients. However, when thinking of themselves as the patient, most participants believed that it would be better for them if they were provided with information and given an opportunity to decide. The interviews revealed some significant harms of family-orientated informed consent, such as delay in treatment, psychological abandonment, and suppression of self-management. This study challenges the widespread assumptions about the benefits of family-oriented informed consent. Some of the harms of this approach are unveiled and discussed. Two opposing attitudes toward this approach to informed consent, derived from the contrasting views of family members and patients, uncover the potential flaws in the beneficence-based justification for this practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.